tetano
Editor, Senior Moderator
J Clin Med
. 2022 Jul 7;11(14):3950.
doi: 10.3390/jcm11143950.
Plasma Endothelial and Oxidative Stress Biomarkers Associated with Late Mortality in Hospitalized COVID-19 Patients
Arturo Orea-Tejada[SUP] 1 [/SUP], Carlos Sánchez-Moreno[SUP] 1 [/SUP], Octavio Gamaliel Aztatzi-Aguilar[SUP] 2 [/SUP], Martha Patricia Sierra-Vargas[SUP] 3 [/SUP], Dulce González-Islas[SUP] 1 [/SUP], Yazmín Debray-García[SUP] 2 [/SUP], Manolo Sibael Ortega-Romero[SUP] 2 [/SUP], Candace Keirns-Davis[SUP] 1 [/SUP], Laura Cornejo-Cornejo[SUP] 1 [/SUP], Jorge Aguilar-Meza[SUP] 1 [/SUP]
Affiliations
Abstract
Background: Coronavirus infectious disease 2019 (COVID-19) is a significant public health problem worldwide. COVID-19 increases the risk of non-pulmonary complications such as acute myocardial injury, renal failure, thromboembolic events, and multi-organic damage. Several studies have documented increased inflammation molecules, endothelial dysfunction biomarkers, and dysregulation of coagulation factors in COVID-19 patients. In addition, endothelium dysfunction is exacerbated by the oxidative stress (OxS) promoted by endocrine and cardiovascular molecules. Our objective was to evaluate whether endothelial and OxS biomarkers were associated with mortality in hospitalized COVID-19 patients.
Methods: A prospective cohort study was performed. Patients ≥18 years old with confirmed COVID-19 that required hospitalization were included in a prospective cohort study. Endothelium and oxidative stress biomarkers were collected between 3 and 5 days after admission.
Results: A total of 165 patients were evaluated; 56 patients succumbed. The median follow-up was 71 days [23-129]. Regarding endothelial dysfunction and OxS biomarkers, patients who did not survive had higher levels of nitrates (0.4564 [0.1817-0.6761] vs. 0.2817 [0.0517-0.5], p = 0.014), total nitrates (0.0507 [-0.0342-0.1809] vs. -0.0041 [-0.0887-0.0909], p = 0.016), sE-Selectin (1.095 [0.86-1.495] vs. 0.94 [0.71-1.19], p = 0.004), and malondialdehyde (MDA) (0.50 [0.26-0.72] vs. 0.36 [0.23-0.52], p = 0.010) compared to patients who survived. Endothelial and OxS biomarkers independently associated with mortality were sE-selectin (HR:2.54, CI95%; from 1.11 to 5.81, p = 0.027), nitrates (HR:4.92, CI95%; from 1.23 to 19.63, p = 0.024), and MDA (HR: 3.05, CI95%; from 1.14 to 8.15, p = 0.025).
Conclusions: Endothelial dysfunction (sE-selectin and nitrates) and OxS (MDA) are independent indicators of a worse prognosis in COVID-19 patients requiring hospitalization.
Keywords: COVID-19; endothelial dysfunction; mortality; oxidative stress.
. 2022 Jul 7;11(14):3950.
doi: 10.3390/jcm11143950.
Plasma Endothelial and Oxidative Stress Biomarkers Associated with Late Mortality in Hospitalized COVID-19 Patients
Arturo Orea-Tejada[SUP] 1 [/SUP], Carlos Sánchez-Moreno[SUP] 1 [/SUP], Octavio Gamaliel Aztatzi-Aguilar[SUP] 2 [/SUP], Martha Patricia Sierra-Vargas[SUP] 3 [/SUP], Dulce González-Islas[SUP] 1 [/SUP], Yazmín Debray-García[SUP] 2 [/SUP], Manolo Sibael Ortega-Romero[SUP] 2 [/SUP], Candace Keirns-Davis[SUP] 1 [/SUP], Laura Cornejo-Cornejo[SUP] 1 [/SUP], Jorge Aguilar-Meza[SUP] 1 [/SUP]
Affiliations
- PMID: 35887714
- DOI: 10.3390/jcm11143950
Abstract
Background: Coronavirus infectious disease 2019 (COVID-19) is a significant public health problem worldwide. COVID-19 increases the risk of non-pulmonary complications such as acute myocardial injury, renal failure, thromboembolic events, and multi-organic damage. Several studies have documented increased inflammation molecules, endothelial dysfunction biomarkers, and dysregulation of coagulation factors in COVID-19 patients. In addition, endothelium dysfunction is exacerbated by the oxidative stress (OxS) promoted by endocrine and cardiovascular molecules. Our objective was to evaluate whether endothelial and OxS biomarkers were associated with mortality in hospitalized COVID-19 patients.
Methods: A prospective cohort study was performed. Patients ≥18 years old with confirmed COVID-19 that required hospitalization were included in a prospective cohort study. Endothelium and oxidative stress biomarkers were collected between 3 and 5 days after admission.
Results: A total of 165 patients were evaluated; 56 patients succumbed. The median follow-up was 71 days [23-129]. Regarding endothelial dysfunction and OxS biomarkers, patients who did not survive had higher levels of nitrates (0.4564 [0.1817-0.6761] vs. 0.2817 [0.0517-0.5], p = 0.014), total nitrates (0.0507 [-0.0342-0.1809] vs. -0.0041 [-0.0887-0.0909], p = 0.016), sE-Selectin (1.095 [0.86-1.495] vs. 0.94 [0.71-1.19], p = 0.004), and malondialdehyde (MDA) (0.50 [0.26-0.72] vs. 0.36 [0.23-0.52], p = 0.010) compared to patients who survived. Endothelial and OxS biomarkers independently associated with mortality were sE-selectin (HR:2.54, CI95%; from 1.11 to 5.81, p = 0.027), nitrates (HR:4.92, CI95%; from 1.23 to 19.63, p = 0.024), and MDA (HR: 3.05, CI95%; from 1.14 to 8.15, p = 0.025).
Conclusions: Endothelial dysfunction (sE-selectin and nitrates) and OxS (MDA) are independent indicators of a worse prognosis in COVID-19 patients requiring hospitalization.
Keywords: COVID-19; endothelial dysfunction; mortality; oxidative stress.